Full text is available at the source.
Abstract
Tirzepatide may offer metabolic and potential kidney protection benefits in patients with advanced chronic kidney disease (CKD).
- Obesity and type 2 diabetes mellitus are linked to faster progression of chronic kidney disease.
- Tirzepatide is designed to activate two specific receptors that may help in managing metabolic health.
- Clinical trials suggest that tirzepatide could provide benefits beyond metabolic improvements, potentially affecting kidney health.
- Real-world effects of tirzepatide in patients with advanced CKD have not been extensively studied.
Simplified